Indomethacin Use in Pain Relief During Intrauterine Device Insertion (INDO-IUD)

Assiut University

Status and phase: Completed; Phase 4

Conditions: Family Planning

Treatments: Drug: indomethacin suppositories; Drug: placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT02711358

INDO

Details and patient eligibility

About

The aim of the investigators study is to test the analgesic effect of rectal indomethacin during Intrauterine device insertion.

Enrollment: 120 patients

Sex: Female

Ages: 20 to 49 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women not taken analgesics or anxiolytics in the 24 hours prior insertion
• Women not taken misoprostol prior to intrauterine device insertion
• Women who will accept to participate in the study

Exclusion criteria

• Any contraindication to intrauterine device placement

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

120 participants in 2 patient groups, including a placebo group

indomethacin

Experimental group

Description:

indomethacin suppositories

Treatment:

Drug: indomethacin suppositories

placebo

Placebo Comparator group

Description:

placebo suppositories

Treatment:

Drug: placebo